A TULSA-PRO Educational Evening
You have been cordially invited to join us for an Educational Evening on The TULSA Procedure during the 2021 American Urological Association Annual meeting. Guest speakers include Christian P. Pavlovich, M.D. and Dr. Stephen Scionti, M.D. and they will provide a comprehensive overview on the TULSA Procedure as a leading innovative, ablative therapy option for prostate conditions.
We look forward to having you join us!
6:00-9:00 p.m. PDT
The Capital Grille – The Magnum Room, Las Vegas
Christian P. Pavlovich, M.D.
Professor of Urology and Oncology
Johns Hopkins Medical Institutions
Director, Urologic Oncology
Johns Hopkins Bayview Medical Center
Director, Urologic Oncology Fellowship
Director, Prostate Cancer Active Surveillance Program
Dr. Christian P. Pavlovich is Professor of Urology at the Johns Hopkins University School of Medicine. He is the Director of Prostate Cancer Active Surveillance Program and Fellowship Director of Urologic Oncology for the Brady Urological Institute.
Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life, while offering patients the latest treatment options and techniques.
His clinical focus is on prostate cancer, kidney cancer, and associated disorders, and on clinical trials regarding cancer detection and cancer immunotherapy. He is experienced in performing open, laparoscopic and other minimally invasive surgeries for the management of urologic tumors, including nerve-sparing and robot-assisted laparoscopic radical prostatectomy, laparoscopic and robotic nephrectomy, nephroureterectomy, and partial nephrectomy, and robotic radical cystectomy. In addition, he offers patients active surveillance and ablative options for their urinary malignancies including cryotherapy and prostate ablation.
He has been a National Institutes of Health- and Department of Defense-funded investigator whose research focuses on identifying early-detection methods for prostate and kidney cancer, including novel urinary biomarkers and imaging modalities for these diseases.
Dr. Pavlovich earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He completed a urology residency at New York Hospital and a National Cancer Institute fellowship in urologic oncology before joining the Hopkins faculty in 2001.
American Board of Urology-certified, Dr. Pavlovich has published over 100 peer-reviewed articles and is on the Editorial Board of the British Journal of Urology International.
Dr. Pavlovich speaks English, French, Spanish, German, Croatian and Serbian.
DR. STEPHEN SCIONTI, M.D
Over the past 20 years Dr. Stephen Scionti has developed the largest and most experienced practice for prostate cancer treatment using minimally invasive thermal ablation technologies such as HIFU, Cryoablation and Prostate Laser Ablation. He has achieved global recognition for his experience, skill and groundbreaking clinical contributions in the field of image-guided prostate cancer ablation. He is also an internationally recognized authority in innovative prostate cancer diagnostics. Beyond his practice, Dr. Scionti actively researches and lectures on the outcomes and technology associated with minimally invasive prostate HIFU therapy ablation.
Dr. Scionti formerly served as Clinical Associate Professor of Urology and Director of Prostate Cancer Ablation Surgery at the Joel E. Smilow Comprehensive Prostate Cancer located at the New York University School of Medicine and Langone Medical Center. Prior to his NYU appointment he was medical director and founder of the Hilton Head, SC International Center for Men’s Health. Dr. Scionti is Founder and Director of the Scionti Prostate Center Sarasota, FL.